{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:35:52Z","timestamp":1794274552884,"version":"4.9.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100018748","name":"Argenx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s12325-023-02704-w","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T04:01:39Z","timestamp":1698984099000},"page":"271-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The Burden Patients with\u00a0Myasthenia Gravis\u00a0Experience in Terms of Breathing, Fatigue, Sleep, Mental Health, Discomfort and Usual Activities in Comparison to the General Population"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7315-3230","authenticated-orcid":false,"given":"S.","family":"Dewilde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-1909","authenticated-orcid":false,"given":"G.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Paci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"De Ruyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9271-5959","authenticated-orcid":false,"given":"N. H.","family":"Tollenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6602-6949","authenticated-orcid":false,"given":"M. F.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"2704_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10112235.","journal-title":"J Clin Med"},{"issue":"1","key":"2704_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12967-021-03185-7","volume":"19","author":"N Salari","year":"2021","unstructured":"Salari N, Fatahi B, Bartina Y, et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med. 2021;19(1):516. https:\/\/doi.org\/10.1186\/s12967-021-03185-7.","journal-title":"J Transl Med"},{"issue":"1","key":"2704_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-2377-10-46","volume":"10","author":"AS Carr","year":"2010","unstructured":"Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10(1):46. https:\/\/doi.org\/10.1186\/1471-2377-10-46.","journal-title":"BMC Neurol"},{"issue":"3","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.pjnns.2017.12.012","volume":"52","author":"IM Rozmilowska","year":"2018","unstructured":"Rozmilowska IM, Adamczyk-Sowa MH, Czyzewski D. The myasthenia gravis-specific activities of daily living scale as a useful outcome measure and in routine clinical management in Polish patients. Neurol Neurochir Pol. 2018;52(3):368\u201373. https:\/\/doi.org\/10.1016\/j.pjnns.2017.12.012.","journal-title":"Neurol Neurochir Pol"},{"issue":"3","key":"2704_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/cei.12217","volume":"175","author":"JP Sieb","year":"2014","unstructured":"Sieb JP. Myasthenia gravis: an update for the clinician. Clin Exp Immunol. 2014;175(3):408\u201318. https:\/\/doi.org\/10.1111\/cei.12217.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"2704_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-015-0298-1","volume":"13","author":"MI Boldingh","year":"2015","unstructured":"Boldingh MI, Dekker L, Maniaol AH, et al. An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts. Health Qual Life Outcomes. 2015;13(1):115. https:\/\/doi.org\/10.1186\/s12955-015-0298-1.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"2704_CR7","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1212\/con.0000000000000800","volume":"25","author":"E Ciafaloni","year":"2019","unstructured":"Ciafaloni E. Myasthenia gravis and congenital myasthenic syndromes. Continuum (Minneap Minn). 2019;25(6):1767\u201384. https:\/\/doi.org\/10.1212\/con.0000000000000800.","journal-title":"Continuum (Minneap Minn)"},{"issue":"7","key":"2704_CR8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9184","volume":"12","author":"C Law","year":"2020","unstructured":"Law C, Flaherty CV, Bandyopadhyay S. A review of psychiatric comorbidity in myasthenia gravis. Cureus. 2020;12(7):e9184. https:\/\/doi.org\/10.7759\/cureus.9184.","journal-title":"Cureus"},{"issue":"10","key":"2704_CR9","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s12325-023-02604-z","volume":"40","author":"S Dewilde","year":"2023","unstructured":"Dewilde S, Phillips G, Paci S, De Ruyck F, Tollenaar NH, Janssen MF. Myasthenia gravis patients have lower HRQoL and need more medical and caregiver help in comparison to the General Population: analysis of two observational studies. Adv Ther. 2023;40(10):4377\u201394. https:\/\/doi.org\/10.1007\/s12325-023-02604-z.","journal-title":"Adv Ther."},{"issue":"7","key":"2704_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048198","volume":"11","author":"S Berrih-Aknin","year":"2021","unstructured":"Berrih-Aknin S, Claeys KG, Law N, et al. Patient-reported impact of myasthenia gravis in the real world: protocol for a digital observational study (MyRealWorld MG). BMJ Open. 2021;11(7): e048198. https:\/\/doi.org\/10.1136\/bmjopen-2020-048198.","journal-title":"BMJ Open"},{"issue":"10","key":"2704_CR11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336. https:\/\/doi.org\/10.1007\/s11136-011-9903-x.","journal-title":"Qual Life Res"},{"issue":"1","key":"2704_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jval.2018.07.001","volume":"22","author":"AP Finch","year":"2019","unstructured":"Finch AP, Brazier JE, Mukuria C. Selecting bolt-on dimensions for the EQ-5D: examining their contribution to health-related quality of life. Value Health. 2019;22(1):50\u201361. https:\/\/doi.org\/10.1016\/j.jval.2018.07.001.","journal-title":"Value Health"},{"issue":"1","key":"2704_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1477-7525-1-54","volume":"1","author":"J Horsman","year":"2003","unstructured":"Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI\u00ae): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1(1):54. https:\/\/doi.org\/10.1186\/1477-7525-1-54.","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"2704_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"2704_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mus.22140","volume":"44","author":"S Muppidi","year":"2011","unstructured":"Muppidi S, Wolfe GI, Conaway M, Burns TM. MG-ADL: still a relevant outcome measure. Muscle Nerve. 2011;44(5):727\u201331. https:\/\/doi.org\/10.1002\/mus.22140.","journal-title":"Muscle Nerve"},{"issue":"1","key":"2704_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.21883","volume":"43","author":"TM Burns","year":"2011","unstructured":"Burns TM, Grouse CK, Wolfe GI, Conaway MR, Sanders DB. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis. Muscle Nerve. 2011;43(1):14\u20138. https:\/\/doi.org\/10.1002\/mus.21883.","journal-title":"Muscle Nerve"},{"issue":"5","key":"2704_CR17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mlr.0000258615.42478.55","volume":"45","author":"D Cella","year":"2007","unstructured":"Cella D, Yount S, Rothrock N, et al. The patient-reported outcomes measurement information system (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45(5):S3\u201311. https:\/\/doi.org\/10.1097\/01.mlr.0000258615.42478.55.","journal-title":"Med Care"},{"key":"2704_CR18","unstructured":"HealthMeasures. Intro to PROMIS\u00ae. 2022. Updated 8 May 2022. https:\/\/www.healthmeasures.net\/explore-measurement-systems\/promis\/intro-to-promis. Accessed 5 Dec 2022."},{"issue":"3","key":"2704_CR19","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s11606-020-06338-4","volume":"36","author":"HHK Weerahandi","year":"2021","unstructured":"Weerahandi HHK, Simon E, Blaum C, et al. Post-discharge health status and symptoms in patients with severe COVID-19. J Gen Intern Med. 2021;36(3):738\u201345. https:\/\/doi.org\/10.1007\/s11606-020-06338-4.","journal-title":"J Gen Intern Med"},{"key":"2704_CR20","unstructured":"HealthMeasures. Interpret Scores - PROMIS\u00ae. Updated 2022. https:\/\/www.healthmeasures.net\/score-and-interpret\/interpret-scores\/promis. Accessed 5 Dec 2022."},{"key":"2704_CR21","unstructured":"HealthMeasures. PROMIS Sleep disturbance scoring manual. Scoring manual. 2021:3, 4. 2022. https:\/\/staging.healthmeasures.net\/images\/PROMIS\/manuals\/PROMIS_Sleep_Disturbance_Scoring_Manual.pdf. Accessed 31 Dec 2022."},{"issue":"2","key":"2704_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the functional assessment of cancer therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13(2):63\u201374. https:\/\/doi.org\/10.1016\/s0885-3924(96)00274-6.","journal-title":"J Pain Symptom Manage"},{"issue":"11","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jval.2018.03.013","volume":"21","author":"I Montan","year":"2018","unstructured":"Montan I, L\u00f6we B, Cella D, Mehnert A, Hinz A. General population norms for the functional assessment of chronic illness therapy (FACIT)-fatigue scale. Value Health. 2018;21(11):1313\u201321. https:\/\/doi.org\/10.1016\/j.jval.2018.03.013.","journal-title":"Value Health"},{"key":"2704_CR24","volume-title":"Straightforward statistics for the behavioral sciences","author":"JD Evans","year":"1996","unstructured":"Evans JD. Straightforward statistics for the behavioral sciences. Berlin: Brooks\/Cole; 1996."},{"key":"2704_CR25","doi-asserted-by":"crossref","unstructured":"Antonini G, Habetswallner F, Inghilleri M, et al. Estimation of myasthenia gravis prevalence in Italy using real-world data. Presented at: XXV World Congress of Neurology; 2021; Virtual Congress.","DOI":"10.1016\/j.jns.2021.118340"},{"issue":"6","key":"2704_CR26","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/mus.26695","volume":"60","author":"G Cutter","year":"2019","unstructured":"Cutter G, Xin H, Aban I, et al. Cross-sectional analysis of the myasthenia gravis patient registry: disability and treatment. Muscle Nerve. 2019;60(6):707\u201315. https:\/\/doi.org\/10.1002\/mus.26695.","journal-title":"Muscle Nerve"},{"key":"2704_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10891-1","author":"S Lehnerer","year":"2021","unstructured":"Lehnerer S, Jacobi J, Schilling R, et al. Burden of disease in myasthenia gravis: taking the patient\u2019s perspective. J Neurol. 2021. https:\/\/doi.org\/10.1007\/s00415-021-10891-1.","journal-title":"J Neurol"},{"issue":"1","key":"2704_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10072-020-04528-w","volume":"42","author":"BK Vitturi","year":"2021","unstructured":"Vitturi BK, Kim AIH, Mitre LP, Pellegrinelli A, Valerio BCO. Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis. Neurol Sci. 2021;42(1):167\u201373. https:\/\/doi.org\/10.1007\/s10072-020-04528-w.","journal-title":"Neurol Sci"},{"issue":"1","key":"2704_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40120-022-00408-x","volume":"12","author":"K Jackson","year":"2023","unstructured":"Jackson K, Parthan A, Lauher-Charest M, Broderick L, Law N, Barnett C. Understanding the symptom burden and impact of myasthenia gravis from the patient\u2019s perspective: a qualitative study. Neurol Ther. 2023;12(1):107\u201328. https:\/\/doi.org\/10.1007\/s40120-022-00408-x.","journal-title":"Neurol Ther"},{"issue":"2","key":"2704_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nmd.2016.11.015","volume":"27","author":"EF Oliveira","year":"2017","unstructured":"Oliveira EF, Nacif SR, Urbano JJ, et al. Sleep, lung function, and quality of life in patients with myasthenia gravis: a cross-sectional study. Neuromuscul Disord. 2017;27(2):120\u20137. https:\/\/doi.org\/10.1016\/j.nmd.2016.11.015.","journal-title":"Neuromuscul Disord"},{"key":"2704_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2022.120268","author":"D Gelinas","year":"2022","unstructured":"Gelinas D, Parvin-Nejad S, Phillips G, et al. The humanistic burden of myasthenia gravis: a systematic literature review. J Neurol Sci. 2022. https:\/\/doi.org\/10.1016\/j.jns.2022.120268.","journal-title":"J Neurol Sci"},{"issue":"4","key":"2704_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s13760-022-01919-y","volume":"122","author":"A Akkan Suzan","year":"2022","unstructured":"Akkan Suzan A, Kahraman Koytak P, Uluc K, Tanridag T. Physical and mental fatigue in myasthenia gravis and its correlation with other symptoms. Acta Neurol Belg. 2022;122(4):915\u201323. https:\/\/doi.org\/10.1007\/s13760-022-01919-y.","journal-title":"Acta Neurol Belg"},{"issue":"2","key":"2704_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/mus.23296","volume":"46","author":"EH Mart\u00ednez-Lapiscina","year":"2012","unstructured":"Mart\u00ednez-Lapiscina EH, Erro ME, Ayuso T, Jeric\u00f3 I. Myasthenia gravis: sleep quality, quality of life, and disease severity. Muscle Nerve. 2012;46(2):174\u201380. https:\/\/doi.org\/10.1002\/mus.23296.","journal-title":"Muscle Nerve"},{"issue":"3","key":"2704_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/cnd.0000000000000321","volume":"22","author":"S Yang","year":"2021","unstructured":"Yang S, Miglis MG, Jaradeh S, Muppidi S. Myasthenia symptom burden, fatigue, and sleep: are they related? J Clin Neuromuscul Dis. 2021;22(3):123\u20138. https:\/\/doi.org\/10.1097\/cnd.0000000000000321.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"1","key":"2704_CR35","doi-asserted-by":"publisher","first-page":"19275","DOI":"10.1038\/s41598-022-22078-3","volume":"12","author":"D Marbin","year":"2022","unstructured":"Marbin D, Piper SK, Lehnerer S, Harms U, Meisel A. Mental health in myasthenia gravis patients and its impact on caregiver burden. Sci Rep. 2022;12(1):19275. https:\/\/doi.org\/10.1038\/s41598-022-22078-3.","journal-title":"Sci Rep"},{"key":"2704_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fepid.2023.1144162","author":"ES Scott","year":"2023","unstructured":"Scott ES, Lubetkin EI, Janssen MF, Yfantopolous J, Bonsel GJ, Haagsma JA. Cross-sectional and longitudinal comparison of health-related quality of life and mental well-being between persons with and without post COVID-19 condition. Front Epidemiol. 2023. https:\/\/doi.org\/10.3389\/fepid.2023.1144162.","journal-title":"Front Epidemiol"},{"key":"2704_CR37","doi-asserted-by":"publisher","first-page":"1072861","DOI":"10.3389\/fneur.2022.1072861","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu X, Li RY, Ye XB, Wang N. Reduced quality of life in myasthenia gravis patients: a study on 185 patients from China. Front Neurol. 2022;13:1072861. https:\/\/doi.org\/10.3389\/fneur.2022.1072861.","journal-title":"Front Neurol"},{"key":"2704_CR38","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3389\/fneur.2020.00604","volume":"11","author":"ME Farrugia","year":"2020","unstructured":"Farrugia ME, Goodfellow JA. A practical approach to managing patients with myasthenia gravis-opinions and a review of the literature. Front Neurol. 2020;11:604. https:\/\/doi.org\/10.3389\/fneur.2020.00604.","journal-title":"Front Neurol"},{"issue":"6","key":"2704_CR39","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1007\/s00415-021-10902-1","volume":"269","author":"LK Andersen","year":"2022","unstructured":"Andersen LK, Jakobsson AS, Revsbech KL, Vissing J. Causes of symptom dissatisfaction in patients with generalized myasthenia gravis. J Neurol. 2022;269(6):3086\u201393. https:\/\/doi.org\/10.1007\/s00415-021-10902-1.","journal-title":"J Neurol"},{"issue":"4","key":"2704_CR40","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00415-021-10759-4","volume":"269","author":"I Bozovic","year":"2022","unstructured":"Bozovic I, Ilic Zivojinovic J, Peric S, et al. Long-term outcome in patients with myasthenia gravis: one decade longitudinal study. J Neurol. 2022;269(4):2039\u201345. https:\/\/doi.org\/10.1007\/s00415-021-10759-4.","journal-title":"J Neurol"},{"key":"2704_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116830","volume":"414","author":"R Anil","year":"2020","unstructured":"Anil R, Kumar A, Alaparthi S, et al. Exploring outcomes and characteristics of myasthenia gravis: rationale, aims and design of registry\u2014The EXPLORE-MG registry. J Neurol Sci. 2020;414: 116830. https:\/\/doi.org\/10.1016\/j.jns.2020.116830.","journal-title":"J Neurol Sci"},{"issue":"1","key":"2704_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/cnd.0000000000000301","volume":"22","author":"L Harris","year":"2020","unstructured":"Harris L, Allman PH, Sheffield R, Cutter G. Longitudinal analysis of disease burden in refractory and nonrefractory generalized myasthenia gravis in the United States. J Clin Neuromuscul Dis. 2020;22(1):11\u201321. https:\/\/doi.org\/10.1097\/cnd.0000000000000301.","journal-title":"J Clin Neuromuscul Dis"},{"key":"2704_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","volume":"8","author":"S Twork","year":"2010","unstructured":"Twork S, Wiesmeth S, Klewer J, P\u00f6hlau D, Kugler J. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes. 2010;8:129. https:\/\/doi.org\/10.1186\/1477-7525-8-129.","journal-title":"Health Qual Life Outcomes"},{"key":"2704_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-015-0298-1","volume":"13","author":"MI Boldingh","year":"2015","unstructured":"Boldingh MI, Dekker L, Maniaol AH, et al. An up-date on health-related quality of life in myasthenia gravis-results from population based cohorts. Health Qual Life Outcomes. 2015;13:115. https:\/\/doi.org\/10.1186\/s12955-015-0298-1.","journal-title":"Health Qual Life Outcomes"},{"key":"2704_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.553626","volume":"11","author":"P Szczudlik","year":"2020","unstructured":"Szczudlik P, Sobieszczuk E, Szyluk B, Lipowska M, Kubiszewska J, Kostera-Pruszczyk A. Determinants of quality of life in myasthenia gravis patients. Front Neurol. 2020;11: 553626. https:\/\/doi.org\/10.3389\/fneur.2020.553626.","journal-title":"Front Neurol"},{"key":"2704_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-94-007-7596-1_5","volume-title":"Self-reported population health: an international perspective based on EQ-5D","author":"A Szende","year":"2014","unstructured":"Szende A, Janssen B. Socio-demographic indicators based on EQ-5D. In: Szende A, Janssen B, Cabases J, editors. Self-reported population health: an international perspective based on EQ-5D. Springer: Netherlands; 2014. p. 37\u201346."},{"key":"2704_CR47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/mb.S70416","volume":"5","author":"DB Resnik","year":"2015","unstructured":"Resnik DB. Bioethical issues in providing financial incentives to research participants. Medicoleg Bioeth. 2015;5:35\u201341. https:\/\/doi.org\/10.2147\/mb.S70416.","journal-title":"Medicoleg Bioeth"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-023-02704-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-023-02704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T07:26:15Z","timestamp":1705562775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-023-02704-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1007\/s12325-023-02704-w","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"26 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sarah Dewilde, the principal investigator of the study, Nafthali H Tollenaar and Mathieu F Janssen have been commissioned by argenx BV and received honoraria to design the study, analyze and report the data. Glenn Phillips, Sandra Paci and Femke De Ruyck are employees of argenx BV, the sponsor of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. All participants signed an informed consent form and ethical committees approved the study in each participating country. The study was performed in accordance with the Declaration of Helsinki. For a full list of participating IRBs, please see the supplementary material.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}